Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Anika Therapeutics (ANIK) Shares Repurchased (2024 - 2025)

Anika Therapeutics (ANIK) has disclosed Shares Repurchased for 3 consecutive years, with $5.5 million as the latest value for Q4 2025.

  • Quarterly Shares Repurchased fell 1.09% to $5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.5 million through Dec 2025, down 13.09% year-over-year, with the annual reading at $9.5 million for FY2025, 13.09% down from the prior year.
  • Shares Repurchased for Q4 2025 was $5.5 million at Anika Therapeutics, up from $4.0 million in the prior quarter.
  • The five-year high for Shares Repurchased was $5.6 million in Q4 2024, with the low at $1.4 million in Q2 2024.